Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | ITK | Q08881 | 4/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22149737 | 0.84 | CA12 (0.38) | EGFRKDM4EMEN1MAPTKMT2A | |
| SCHEMBL22149955 | 0.83 | SMN1; SMN2 (0.38) | EGFRKDM4EMEN1MAPTKMT2A | |
| SCHEMBL22150196 | 0.82 | HDAC8 (0.39) | HDAC8HDAC3NCOR2 | |
| SCHEMBL22149736 | 0.82 | HDAC8 (0.40) | HDAC8HDAC3NCOR2 | |
| SCHEMBL23810206 | 0.72 | KDM4E (0.41) | KDM4EHDAC8HDAC3 | |
| SCHEMBL17060912 | 0.71 | P4HTM (0.37) | KDM4EMEN1MAPTKMT2AHDAC8 | |
| SCHEMBL17060910 | 0.71 | P4HTM (0.37) | KDM4EMEN1MAPTKMT2AHDAC8 | |
| SCHEMBL22150193 | 0.71 | GAA (0.39) | KDM4EMEN1MAPTKMT2ACA12 | |
| SCHEMBL22122705 | 0.70 | SMN1; SMN2 (0.41) | KDM4EMEN1MAPTKMT2AHDAC8 | |
| SCHEMBL22122701 | 0.70 | CYP1A1 (0.46) | KDM4EMEN1MAPTKMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018103-B2 | Flow cell and methods | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-06-25 | — | — | US | disclosed |
| US-20220372182-A1 | FLOW CELL AND METHODS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-11-24 | — | — | US | disclosed |
| US-20220185927-A1 | HYDROGEL | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-06-16 | — | — | US | disclosed |
| US-20210284609-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-09-16 | — | — | US | disclosed |
| WO-2021110700-A1 | HYDROGEL | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-06-10 | — | — | WO | disclosed |
| WO-2020126598-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284609-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | POLL, PCNA, DNMT3A | EGFR 1973/4885KDM4E 3663/4885MEN1 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.